Brain Tumor News!
Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
07/20/01
Weird News: The Wolf Files
(ABCNEWS.com)
Famed Ringling Bros. and Barnum and Bailey Circus animal handler Gunther Gebel-Williams died from
cancer at age 66.
07/19/01
PrimeTime: Survival at South Pole
(ABCNEWS.com)
Jerri Nielsen, the doctor who treated herself for breast
cancer until she was rescued from the South Pole, updates her remarkable story. And it includes a return to Antarctica. Read the from her book.
07/19/01
Trainer Gunther Gebel-Williams Dies
(Associated Press)
Gunther Gebel-Williams, the circus animal trainer who delighted ladies and gentlemen, children of all ages, during his three decades with the Greatest Show on Earth, died of
cancer Thursday at 66.
07/19/01
Allos Therapeutics Reports Second Quarter 2001 Financial Results
(PR Newswire)
... randomized study of RSR13 combined with standard whole
brain radiation therapy versus standard whole
brain radiation...... Phase 3 trial for the treatment of metastatic
brain tumors with its lead clinical candidate,......By increasing
tumor oxygenation,...
07/19/01
Bush Signs Law for Reagan's Daughter
(Associated Press)
... radiation treatments for melanoma that has spread to her
brain.......Last November, a golf ball-sized malignant
tumor was discovered in her right pubic bone and she underwent...... July and an MRI performed July 6 confirmed two
brain tumors,...
07/18/01
Seniors will suffer as HMOs cut back
(Detroit Free Press)Joan Ellery has a failing heart and is partially paralyzed from a
brain tumor. Her husband, Bernard, a retired tool-and-die worker, has glaucoma and heart problems. He hasn't worked since his 1990 colon cancer surgery.
07/18/01
MGI PHARMA Reports 2001 Second Quarter Results
(Business Wire)... recurrent malignant glioma, the most common type of
brain cancer,...... Gemzar(R)in approximately 30 patients with advanced solid
tumors....... irofulven, as well as a summary of irofulven's anti-
tumor activity across Phase 1 and 2 trials....